Yahoo
HKSE - Delayed Quote HKD

QingSong Health Corporation (2661.HK)

3.175 -0.005 (-0.16%)
As of 1:50:13 PM GMT+8. Market Open.
Chart Range Bar
Loading chart for 2661.HK
  • Previous Close 3.180
  • Open 3.255
  • Bid 3.180 x --
  • Ask 3.185 x --
  • Day's Range 3.175 - 3.375
  • 52 Week Range 2.630 - 162.700
  • Volume 15,914,600
  • Avg. Volume 15,769,619
  • Market Cap (intraday) 641.33M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -2.800
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

QingSong Health Corporation provides healthcare-related and insurance-related services in China. The company offers digital marketing through healthcare-related educational articles and videos; digital medical research assistance; integrated health service packages with various self-operated and outsourced services; and promotion and consultancy to support early disease screening. It also provides Insurance Brokerage services; and a suite of technical services including smart operations, smart risk control, and smart monitoring through i-Phoenix enterprise service platform. The company was formerly known as QingSongChou Corporation and changed its name to QingSong Health Corporation in September 2020. The company was incorporated in 2014 and is headquartered in Beijing, The People's Republic of China.

www.qingsonghealth.com

206

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2661.HK
95.36%
HANG SENG INDEX (^HSI)
3.92%

1-Year Return

2661.HK
93.65%
HANG SENG INDEX (^HSI)
5.05%

3-Year Return

2661.HK
93.65%
HANG SENG INDEX (^HSI)
39.41%

5-Year Return

2661.HK
93.65%
HANG SENG INDEX (^HSI)
0.98%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -53.98%

  • Return on Assets (ttm)

    -1.96%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    957.97M

  • Net Income Avi to Common (ttm)

    -517.12M

  • Diluted EPS (ttm)

    -2.800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    747.92M

  • Total Debt/Equity (mrq)

    0.27%

  • Levered Free Cash Flow (ttm)

    -88.26M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: